1. |
柳涛, 蔡柏蔷. 慢性阻塞性肺疾病诊断、处理和预防全球策略(2011 年修订版)介绍. 中国呼吸与危重监护杂志, 2012, 11(1):1-12.0.
|
2. |
Vestbo J., Hurd SS., Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2013, 187(4): 347-365.
|
3. |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. Respirology, 2017, 22(3): 128-149.
|
4. |
庞才双, 曾妮, 申永春, 等. 慢性阻塞性肺疾病气道重塑机制及其研究进展. 西部医学, 2017, 29(1):135-140.0.
|
5. |
Ota C, Baarsma HA, Wagner DE, et al. Linking bronchopulmonary dysplasia to adult chronic lung diseases: role of WNT signaling. Mol Cell Pediatr, 2016, 3(1):34.
|
6. |
Caprioli A, Villasenor A, Wylie L A, et al. Wnt4 is essential to normal mammalian lung development. Dev Biol, 2015, 406(2): 222-234.
|
7. |
Lehmann M, Baarsma HA, Konigshoff M. WNT signaling in lung aging and disease. Ann Am Thorac Soc, 2016, 13(Suppl 5): S411-S416.
|
8. |
Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci, 2003, 116(Pt 13): 2627-2634.
|
9. |
van Amerongen R, Berns A. Knockout mouse models to study Wnt signal transduction. Trends Genet, 2006, 22(12): 678-689.
|
10. |
Uhl FE, Vierkotten S, Wagner DE, et al. Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur Respir J, 2015, 46(4):1150-1166.
|
11. |
Foronjy R, Imai K, Shiomi T, et al. The divergent roles of secreted frizzled related protein-1 (SFRP1) in lung morphogenesis and emphysema. Am J Pathol, 2010, 177(2): 598-607.
|
12. |
丁宁, 王胜. 慢性阻塞性肺疾病发病机制最新研究进展. 临床肺科杂志, 2016, 21(1):133-136.0.
|
13. |
Kneidinger N, Yildirim AO, Callegari J, et al. Activation of the WNT/beta-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med, 2011, 183(6): 723-733.
|
14. |
Heijink IH, de Bruin HG, van den Berge M, et al. Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease. Thorax, 2013, 68(8):709-716.
|
15. |
Wang R, Ahmed J, Wang G, et al. Down-regulation of the canonical Wnt beta-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD. PLoS One, 2011, 6(4):e14793.
|
16. |
Ren J, Wang R, Huang G, et al. sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line. Cancer Biother Radiopharm, 2013, 28(7): 565-571.
|
17. |
景霞, 许建英. 吸烟对大鼠气道上皮细胞基质金属蛋白酶 9 表达的影响. 中国呼吸与危重监护杂志, 2009, 8(3):220-223.0.
|
18. |
Wang A, Zsengeller ZK, Hecht JL, et al. Excess placental secreted frizzled-related protein 1 in maternal smokers impairs fetal growth. J Clin Invest, 2015, 125(11):4021-4025.
|
19. |
Bartis D, Mise N, Mahida RY, et al. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? Thorax, 2014, 69(8):760-765.
|
20. |
Nowrin K, Sohal SS, Peterson G, et al. Epithelial-mesenchymal transition as a fundamental underlying pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev Respir Med, 2014, 8(5):547-559.
|
21. |
Pain M, Bermudez O, Lacoste P, et al. Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. Eur Respir Rev, 2014, 23(131): 118-130.
|